ArticleLiver international : official journal of the International Association for the Study of the Liver2025

Target Trial Emulations of GLP-1 and Dual GLP-1/GIP Agonists to Reduce Major Adverse Liver Outcomes in Type 2 Diabetes.

Alex E Henney et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.